Innovation Fund Sabbaticals

Overview

  • Eligibility: Open to all SUMO physicians
  • Matching Funds: Practice plans must match the SUMO contribution using their own resources
  • Travel Not Required: Sabbaticals may be completed locally
$0
Total Funding Available
$0
Maximum Per Physician

Overview

  • Eligibility: Open to all SUMO physicians
  • Matching Funds: Practice plans must match the SUMO contribution using their own resources
  • Travel Not Required: Sabbaticals may be completed locally
$0
Total Funding Available
$0
Maximum Per Physician

Application Process

Applicants must submit the form titled ‘P1 – Innovation Fund Sabbatical Proposal’ (link) and address the following funding criteria:

  • Identified Gap: Does the proposed therapy or approach currently exist in Ontario?
  • Innovation: What is the clearly defined innovation, and how does it improve upon current practice?
  • Potential Impact: Can this innovation be realistically implemented in Ontario?
  • Proposal Quality: Strength of the proposal and the applicant’s qualifications and experience

Submission Process

Practice plans are responsible for collecting and coordinating the submission of all applications from their members.

Supporting Documents

For full program details and application materials, please refer to the SUMO Innovation Fund Sabbaticals Policy for further details on eligibility requirements, processes and timelines.

Innovation Fund Sabbatical Awardees

2024

  • Dr. Tulin Cil (UHN General Surgery) – Prevention of Breast Cancer-Related Lymphedema Using the Simplified Lymphatic Microsurgical Preventing
    Healing Approach (S-LYMPHA)
  • Dr. Neil Fleshner (UHN Urology) – Targeting Recurrent Prostate Cancer Using a Theranostic Radiopharmaceutical Approach
  • Dr. Jia Zhimeng (MSH Palliative Care) – Speaking Compassionately with seriously ill Chinese Immigrants and their Caregivers (仁医仁语)
  • Dr. Samir Sinha (Medicine) – How Should Sinai Health Consider Implementing the Hospital at Home Model of Care?
  • Dr. Alexandre Zlotta (MSH Surgery) – PRISM – A globally accessible, patient-oriented artificial intelligence-based model to predict the presence
    of clinically significant prostate cancer

2025

  • Dr. Michael Fralick (Medicine) – Evaluating risks and benefits of Newer Diabetes medications when Used in Routine care [ENDURe]
  • Dr. Anahi Perlas (Anesthesia) -Incorporating Equity, Diversity and Inclusion into the TWH Anesthesia Research Program
    2026
  • Dr. Chung-Wai Chow (Medicine) – Implementation of Respiratory Oscillometry into Routine Clinical Practice
  • Dr. Dean Elterman (UHN Urology) – Establishing a Holmium Laser Enucleation of the Prostate (HoLEP) Program at UHN
  • Dr. Andrea Furlan (UHN Rehabilitation Medicine) – Improving the Care for People with Chronic Nociplastic Pain in Ontario with innovative and
    evidence-based assessments and therapies
  • Dr. Rebeccas Gladdy (MSH Surgery) – STAMP – Smooth Muscle Tumor At Risk Molecular Prognosticator – A globally accessible AI tool to predict
    patients at risk of early stage and advanced leiomyosarcoma
  • Dr. Ewan Goligher (Medicine) -Research ethics training for a learning health system
  • Dr. Andrew Hope (UNH Radiation Oncology) – Developing multi-agent AI decision support system for patients with thoracic malignancies
  • Dr. Robert Wu (Medicine) – Advancing a Research Remote Monitoring Platform Through Global Perspectives, New Networks and Deep Work